Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK.
about
Neutrophil gelatinase-associated lipocalin mediates 13-cis retinoic acid-induced apoptosis of human sebaceous gland cellsThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesKrüppel-like factor 4 inhibits proliferation by platelet-derived growth factor receptor beta-mediated, not by retinoic acid receptor alpha-mediated, phosphatidylinositol 3-kinase and ERK signaling in vascular smooth muscle cellsDi(2-ethylhexyl) phthalate induces apoptosis through peroxisome proliferators-activated receptor-gamma and ERK 1/2 activation in testis of Sprague-Dawley ratsω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell linesRibavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.Function of PPARgamma and its ligands in lung cancer.Histone deacetylase inhibitors induce CXCR4 mRNA but antagonize CXCR4 migrationAll-trans retinoic acid modulates mitogen-activated protein kinase pathway activation in human scleral fibroblasts through retinoic acid receptor beta.Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.Complementary PTM Profiling of Drug Response in Human Gastric Carcinoma by Immunoaffinity and IMAC Methods with Total Proteome Analysis.MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A.Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.RARβ2-dependent signaling represses neuronal differentiation in mouse ES cells.
P2860
Q24657556-424BA459-15A3-4611-9626-389FA6C601FFQ28238709-E0B96D7F-5483-483E-967C-14B4E86A2835Q28566073-309D6204-A9B5-40EA-926B-EB853C33C25BQ28580186-D06EDC1D-0F85-4372-9FF9-E254FFEC0D69Q33774367-96770D3E-0356-41D5-85E4-F9CAF6492236Q34917506-65101F95-F136-4B0E-A928-06313ED59809Q36414175-7AF4CB43-471A-4838-90C2-6DB0BC7F131BQ36608727-EADFB2D6-26F3-46E6-93AD-BED35E4AD4F2Q37091576-EA0531ED-C1DB-493B-808B-C7D276711236Q37446199-4C2AD202-E842-474D-BF5D-9B8DC1740A31Q38846152-79861DB9-DACD-4749-82D7-0D34124334C6Q38930849-D3222405-A6C1-4A50-8DDA-19E6F324E358Q40055706-70CD1467-E531-42C3-8327-4FBFE6858FF1Q47386833-2840BB72-2ED3-48D1-9155-7FE1A062646F
P2860
Enhanced retinoid-induced apoptosis of MDA-MB-231 breast cancer cells by PKC inhibitors involves activation of ERK.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Enhanced retinoid-induced apop ...... rs involves activation of ERK.
@en
type
label
Enhanced retinoid-induced apop ...... rs involves activation of ERK.
@en
prefLabel
Enhanced retinoid-induced apop ...... rs involves activation of ERK.
@en
P2093
P2860
P356
P1433
P1476
Enhanced retinoid-induced apop ...... rs involves activation of ERK.
@en
P2093
Filippa Pettersson
Marie-Claude Couture
Nessrine Hanna
Wilson H Miller
P2860
P2888
P304
P356
10.1038/SJ.ONC.1207956
P407
P577
2004-09-01T00:00:00Z
P5875
P6179
1046866367